Short Interest in WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Declines By 81.8%

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) saw a significant decline in short interest during the month of July. As of July 31st, there was short interest totaling 46,353 shares, a decline of 81.8% from the July 15th total of 255,103 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily volume of 113,253 shares, the short-interest ratio is presently 0.4 days.

WuXi Biologics (Cayman) Stock Down 0.7%

WuXi Biologics (Cayman) stock opened at $11.56 on Friday. The business has a 50 day moving average of $9.29 and a 200-day moving average of $9.16. WuXi Biologics has a 1 year low of $7.30 and a 1 year high of $11.88.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.